Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial

Chinese General Practice Journal · Elsevier

Аннотация

Publication date: 17 November 2026 Source: Cell Reports Medicine, Volume 7, Issue 11 Author(s): Mengmeng Wang, Wei Wu, Quanming Zheng, Hao Zhou, Jiecheng Ren, Huixing Gou, Xue’er Meng, Guanbao Cui, Jingjing Sun, Jiahui Zhou, Xiyun Chen, Jian Guo, Shikang Li, Zhen He, Dexue Ge, Gang Wang, Qiuyu Yuan, Dongliang Jiao, Xinming Yu, Bin Wang

Читать у издателя →

Похожие статьи